Global Type 2 Diabetes Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
- GLO2765398
- 122 Pages
- September 2018
- Pharmaceuticals
Scope of the Report:
This report focuses on the Type 2 Diabetes in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The dramatic increase in the prevalence, progressive nature and diagnosis of type 2 diabetes is the main driver of this rapid growth rate. The rise in disease-related comorbidities has also fuelled a more aggressive approach to treatment, including the use of multiple-drug therapies.
The Americas dominated the global type 1 diabetes drug market and accounted for close to 50% of the global type 1 diabetes market size. The US was the largest revenue contributor to the diabetes drug market in this region because of the growing prevalence of the disease and rise in obesity. The accessibility to therapies by reimbursement programs is further expected to drive the growth of the diabetes drug market size in the Americas.
The worldwide market for Type 2 Diabetes is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Novo Nordisk
Sanofi
Merck
Eli Lily
AstraZeneca
Astellas Pharma
Daiichi Sankyo
Biocon
Boehringer Ingelheim
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Insulins
DPP-4 Inhibitors
GLP-1 Receptor Agonists
SGLT-2 Inhibitors
Market Segment by Applications, can be divided into
Drugstore
Hospital
Others
There are 15 Chapters to deeply display the global Type 2 Diabetes market.
Chapter 1, to describe Type 2 Diabetes Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Type 2 Diabetes, with sales, revenue, and price of Type 2 Diabetes, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Type 2 Diabetes, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Type 2 Diabetes market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Type 2 Diabetes sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
1 Market Overview
1.1 Type 2 Diabetes Introduction
1.2 Market Analysis by Type
1.2.1 Insulins
1.2.2 DPP-4 Inhibitors
1.2.3 GLP-1 Receptor Agonists
1.2.4 SGLT-2 Inhibitors
1.3 Market Analysis by Applications
1.3.1 Drugstore
1.3.2 Hospital
1.3.3 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Novo Nordisk
2.1.1 Business Overview
2.1.2 Type 2 Diabetes Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Novo Nordisk Type 2 Diabetes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Sanofi
2.2.1 Business Overview
2.2.2 Type 2 Diabetes Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Sanofi Type 2 Diabetes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Merck
2.3.1 Business Overview
2.3.2 Type 2 Diabetes Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Merck Type 2 Diabetes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Eli Lily
2.4.1 Business Overview
2.4.2 Type 2 Diabetes Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Eli Lily Type 2 Diabetes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 AstraZeneca
2.5.1 Business Overview
2.5.2 Type 2 Diabetes Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 AstraZeneca Type 2 Diabetes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Astellas Pharma
2.6.1 Business Overview
2.6.2 Type 2 Diabetes Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Astellas Pharma Type 2 Diabetes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Daiichi Sankyo
2.7.1 Business Overview
2.7.2 Type 2 Diabetes Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Daiichi Sankyo Type 2 Diabetes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Biocon
2.8.1 Business Overview
2.8.2 Type 2 Diabetes Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Biocon Type 2 Diabetes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Boehringer Ingelheim
2.9.1 Business Overview
2.9.2 Type 2 Diabetes Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Boehringer Ingelheim Type 2 Diabetes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Type 2 Diabetes Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Type 2 Diabetes Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Type 2 Diabetes Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Type 2 Diabetes Manufacturer Market Share in 2017
3.3.2 Top 6 Type 2 Diabetes Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Type 2 Diabetes Market Analysis by Regions
4.1 Global Type 2 Diabetes Sales, Revenue and Market Share by Regions
4.1.1 Global Type 2 Diabetes Sales and Market Share by Regions (2013-2018)
4.1.2 Global Type 2 Diabetes Revenue and Market Share by Regions (2013-2018)
4.2 North America Type 2 Diabetes Sales and Growth Rate (2013-2018)
4.3 Europe Type 2 Diabetes Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Type 2 Diabetes Sales and Growth Rate (2013-2018)
4.5 South America Type 2 Diabetes Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Type 2 Diabetes Sales and Growth Rate (2013-2018)
5 North America Type 2 Diabetes by Countries
5.1 North America Type 2 Diabetes Sales, Revenue and Market Share by Countries
5.1.1 North America Type 2 Diabetes Sales and Market Share by Countries (2013-2018)
5.1.2 North America Type 2 Diabetes Revenue and Market Share by Countries (2013-2018)
5.2 United States Type 2 Diabetes Sales and Growth Rate (2013-2018)
5.3 Canada Type 2 Diabetes Sales and Growth Rate (2013-2018)
5.4 Mexico Type 2 Diabetes Sales and Growth Rate (2013-2018)
6 Europe Type 2 Diabetes by Countries
6.1 Europe Type 2 Diabetes Sales, Revenue and Market Share by Countries
6.1.1 Europe Type 2 Diabetes Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Type 2 Diabetes Revenue and Market Share by Countries (2013-2018)
6.2 Germany Type 2 Diabetes Sales and Growth Rate (2013-2018)
6.3 UK Type 2 Diabetes Sales and Growth Rate (2013-2018)
6.4 France Type 2 Diabetes Sales and Growth Rate (2013-2018)
6.5 Russia Type 2 Diabetes Sales and Growth Rate (2013-2018)
6.6 Italy Type 2 Diabetes Sales and Growth Rate (2013-2018)
7 Asia-Pacific Type 2 Diabetes by Countries
7.1 Asia-Pacific Type 2 Diabetes Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Type 2 Diabetes Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Type 2 Diabetes Revenue and Market Share by Countries (2013-2018)
7.2 China Type 2 Diabetes Sales and Growth Rate (2013-2018)
7.3 Japan Type 2 Diabetes Sales and Growth Rate (2013-2018)
7.4 Korea Type 2 Diabetes Sales and Growth Rate (2013-2018)
7.5 India Type 2 Diabetes Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Type 2 Diabetes Sales and Growth Rate (2013-2018)
8 South America Type 2 Diabetes by Countries
8.1 South America Type 2 Diabetes Sales, Revenue and Market Share by Countries
8.1.1 South America Type 2 Diabetes Sales and Market Share by Countries (2013-2018)
8.1.2 South America Type 2 Diabetes Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Type 2 Diabetes Sales and Growth Rate (2013-2018)
8.3 Argentina Type 2 Diabetes Sales and Growth Rate (2013-2018)
8.4 Colombia Type 2 Diabetes Sales and Growth Rate (2013-2018)
9 Middle East and Africa Type 2 Diabetes by Countries
9.1 Middle East and Africa Type 2 Diabetes Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Type 2 Diabetes Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Type 2 Diabetes Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Type 2 Diabetes Sales and Growth Rate (2013-2018)
9.3 UAE Type 2 Diabetes Sales and Growth Rate (2013-2018)
9.4 Egypt Type 2 Diabetes Sales and Growth Rate (2013-2018)
9.5 Nigeria Type 2 Diabetes Sales and Growth Rate (2013-2018)
9.6 South Africa Type 2 Diabetes Sales and Growth Rate (2013-2018)
10 Global Type 2 Diabetes Market Segment by Type
10.1 Global Type 2 Diabetes Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Type 2 Diabetes Sales and Market Share by Type (2013-2018)
10.1.2 Global Type 2 Diabetes Revenue and Market Share by Type (2013-2018)
10.2 Insulins Sales Growth and Price
10.2.1 Global Insulins Sales Growth (2013-2018)
10.2.2 Global Insulins Price (2013-2018)
10.3 DPP-4 Inhibitors Sales Growth and Price
10.3.1 Global DPP-4 Inhibitors Sales Growth (2013-2018)
10.3.2 Global DPP-4 Inhibitors Price (2013-2018)
10.4 GLP-1 Receptor Agonists Sales Growth and Price
10.4.1 Global GLP-1 Receptor Agonists Sales Growth (2013-2018)
10.4.2 Global GLP-1 Receptor Agonists Price (2013-2018)
10.5 SGLT-2 Inhibitors Sales Growth and Price
10.5.1 Global SGLT-2 Inhibitors Sales Growth (2013-2018)
10.5.2 Global SGLT-2 Inhibitors Price (2013-2018)
11 Global Type 2 Diabetes Market Segment by Application
11.1 Global Type 2 Diabetes Sales Market Share by Application (2013-2018)
11.2 Drugstore Sales Growth (2013-2018)
11.3 Hospital Sales Growth (2013-2018)
11.4 Others Sales Growth (2013-2018)
12 Type 2 Diabetes Market Forecast (2018-2023)
12.1 Global Type 2 Diabetes Sales, Revenue and Growth Rate (2018-2023)
12.2 Type 2 Diabetes Market Forecast by Regions (2018-2023)
12.2.1 North America Type 2 Diabetes Market Forecast (2018-2023)
12.2.2 Europe Type 2 Diabetes Market Forecast (2018-2023)
12.2.3 Asia-Pacific Type 2 Diabetes Market Forecast (2018-2023)
12.2.4 South America Type 2 Diabetes Market Forecast (2018-2023)
12.2.5 Middle East and Africa Type 2 Diabetes Market Forecast (2018-2023)
12.3 Type 2 Diabetes Market Forecast by Type (2018-2023)
12.3.1 Global Type 2 Diabetes Sales Forecast by Type (2018-2023)
12.3.2 Global Type 2 Diabetes Market Share Forecast by Type (2018-2023)
12.4 Type 2 Diabetes Market Forecast by Application (2018-2023)
12.4.1 Global Type 2 Diabetes Sales Forecast by Application (2018-2023)
12.4.2 Global Type 2 Diabetes Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
Figure Type 2 Diabetes Picture
Table Product Specifications of Type 2 Diabetes
Figure Global Sales Market Share of Type 2 Diabetes by Types in 2017
Table Type 2 Diabetes Types for Major Manufacturers
Figure Insulins Picture
Figure DPP-4 Inhibitors Picture
Figure GLP-1 Receptor Agonists Picture
Figure SGLT-2 Inhibitors Picture
Figure Type 2 Diabetes Sales Market Share by Applications in 2017
Figure Drugstore Picture
Figure Hospital Picture
Figure Others Picture
Figure United States Type 2 Diabetes Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Type 2 Diabetes Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Type 2 Diabetes Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Type 2 Diabetes Revenue (Value) and Growth Rate (2013-2023)
Figure France Type 2 Diabetes Revenue (Value) and Growth Rate (2013-2023)
Figure UK Type 2 Diabetes Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Type 2 Diabetes Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Type 2 Diabetes Revenue (Value) and Growth Rate (2013-2023)
Figure China Type 2 Diabetes Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Type 2 Diabetes Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Type 2 Diabetes Revenue (Value) and Growth Rate (2013-2023)
Figure India Type 2 Diabetes Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Type 2 Diabetes Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Type 2 Diabetes Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Type 2 Diabetes Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Type 2 Diabetes Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Type 2 Diabetes Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Type 2 Diabetes Revenue (Value) and Growth Rate (2013-2023)
Table Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table Novo Nordisk Type 2 Diabetes Type and Applications
Table Novo Nordisk Type 2 Diabetes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Type 2 Diabetes Type and Applications
Table Sanofi Type 2 Diabetes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Type 2 Diabetes Type and Applications
Table Merck Type 2 Diabetes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Eli Lily Basic Information, Manufacturing Base and Competitors
Table Eli Lily Type 2 Diabetes Type and Applications
Table Eli Lily Type 2 Diabetes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Type 2 Diabetes Type and Applications
Table AstraZeneca Type 2 Diabetes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Astellas Pharma Basic Information, Manufacturing Base and Competitors
Table Astellas Pharma Type 2 Diabetes Type and Applications
Table Astellas Pharma Type 2 Diabetes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table Daiichi Sankyo Type 2 Diabetes Type and Applications
Table Daiichi Sankyo Type 2 Diabetes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Biocon Basic Information, Manufacturing Base and Competitors
Table Biocon Type 2 Diabetes Type and Applications
Table Biocon Type 2 Diabetes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table Boehringer Ingelheim Type 2 Diabetes Type and Applications
Table Boehringer Ingelheim Type 2 Diabetes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Type 2 Diabetes Sales by Manufacturer (2016-2017)
Figure Global Type 2 Diabetes Sales Market Share by Manufacturer in 2016
Figure Global Type 2 Diabetes Sales Market Share by Manufacturer in 2017
Table Global Type 2 Diabetes Revenue by Manufacturer (2016-2017)
Figure Global Type 2 Diabetes Revenue Market Share by Manufacturer in 2016
Figure Global Type 2 Diabetes Revenue Market Share by Manufacturer in 2017
Figure Top 3 Type 2 Diabetes Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Type 2 Diabetes Manufacturer (Revenue) Market Share in 2017
Figure Global Type 2 Diabetes Sales and Growth Rate (2013-2018)
Figure Global Type 2 Diabetes Revenue and Growth Rate (2013-2018)
Table Global Type 2 Diabetes Sales by Regions (2013-2018)
Table Global Type 2 Diabetes Sales Market Share by Regions (2013-2018)
Table Global Type 2 Diabetes Revenue by Regions (2013-2018)
Figure Global Type 2 Diabetes Revenue Market Share by Regions in 2013
Figure Global Type 2 Diabetes Revenue Market Share by Regions in 2017
Figure North America Type 2 Diabetes Sales and Growth Rate (2013-2018)
Figure Europe Type 2 Diabetes Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Type 2 Diabetes Sales and Growth Rate (2013-2018)
Figure South America Type 2 Diabetes Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Type 2 Diabetes Sales and Growth Rate (2013-2018)
Figure North America Type 2 Diabetes Revenue and Growth Rate (2013-2018)
Table North America Type 2 Diabetes Sales by Countries (2013-2018)
Table North America Type 2 Diabetes Sales Market Share by Countries (2013-2018)
Figure North America Type 2 Diabetes Sales Market Share by Countries in 2013
Figure North America Type 2 Diabetes Sales Market Share by Countries in 2017
Table North America Type 2 Diabetes Revenue by Countries (2013-2018)
Table North America Type 2 Diabetes Revenue Market Share by Countries (2013-2018)
Figure North America Type 2 Diabetes Revenue Market Share by Countries in 2013
Figure North America Type 2 Diabetes Revenue Market Share by Countries in 2017
Figure United States Type 2 Diabetes Sales and Growth Rate (2013-2018)
Figure Canada Type 2 Diabetes Sales and Growth Rate (2013-2018)
Figure Mexico Type 2 Diabetes Sales and Growth Rate (2013-2018)
Figure Europe Type 2 Diabetes Revenue and Growth Rate (2013-2018)
Table Europe Type 2 Diabetes Sales by Countries (2013-2018)
Table Europe Type 2 Diabetes Sales Market Share by Countries (2013-2018)
Table Europe Type 2 Diabetes Revenue by Countries (2013-2018)
Figure Europe Type 2 Diabetes Revenue Market Share by Countries in 2016
Figure Europe Type 2 Diabetes Revenue Market Share by Countries in 2017
Figure Germany Type 2 Diabetes Sales and Growth Rate (2013-2018)
Figure UK Type 2 Diabetes Sales and Growth Rate (2013-2018)
Figure France Type 2 Diabetes Sales and Growth Rate (2013-2018)
Figure Russia Type 2 Diabetes Sales and Growth Rate (2013-2018)
Figure Italy Type 2 Diabetes Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Type 2 Diabetes Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Type 2 Diabetes Sales by Countries (2013-2018)
Table Asia-Pacific Type 2 Diabetes Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Type 2 Diabetes Sales Market Share by Countries 2017
Table Asia-Pacific Type 2 Diabetes Revenue by Countries (2013-2018)
Figure Asia-Pacific Type 2 Diabetes Revenue Market Share by Countries 2017
Figure China Type 2 Diabetes Sales and Growth Rate (2013-2018)
Figure Japan Type 2 Diabetes Sales and Growth Rate (2013-2018)
Figure Korea Type 2 Diabetes Sales and Growth Rate (2013-2018)
Figure India Type 2 Diabetes Sales and Growth Rate (2013-2018)
Figure Southeast Asia Type 2 Diabetes Sales and Growth Rate (2013-2018)
Figure South America Type 2 Diabetes Revenue and Growth Rate (2013-2018)
Table South America Type 2 Diabetes Sales by Countries (2013-2018)
Table South America Type 2 Diabetes Sales Market Share by Countries (2013-2018)
Figure South America Type 2 Diabetes Sales Market Share by Countries in 2017
Table South America Type 2 Diabetes Revenue by Countries (2013-2018)
Table South America Type 2 Diabetes Revenue Market Share by Countries (2013-2018)
Figure South America Type 2 Diabetes Revenue Market Share by Countries in 2017
Figure Brazil Type 2 Diabetes Sales and Growth Rate (2013-2018)
Figure Argentina Type 2 Diabetes Sales and Growth Rate (2013-2018)
Figure Colombia Type 2 Diabetes Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Type 2 Diabetes Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Type 2 Diabetes Sales by Countries (2013-2018)
Table Middle East and Africa Type 2 Diabetes Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Type 2 Diabetes Sales Market Share by Countries in 2017
Table Middle East and Africa Type 2 Diabetes Revenue by Countries (2013-2018)
Table Middle East and Africa Type 2 Diabetes Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Type 2 Diabetes Revenue Market Share by Countries in 2013
Figure Middle East and Africa Type 2 Diabetes Revenue Market Share by Countries in 2017
Figure Saudi Arabia Type 2 Diabetes Sales and Growth Rate (2013-2018)
Figure UAE Type 2 Diabetes Sales and Growth Rate (2013-2018)
Figure Egypt Type 2 Diabetes Sales and Growth Rate (2013-2018)
Figure Nigeria Type 2 Diabetes Sales and Growth Rate (2013-2018)
Figure South Africa Type 2 Diabetes Sales and Growth Rate (2013-2018)
Table Global Type 2 Diabetes Sales by Type (2013-2018)
Table Global Type 2 Diabetes Sales Share by Type (2013-2018)
Table Global Type 2 Diabetes Revenue by Type (2013-2018)
Table Global Type 2 Diabetes Revenue Share by Type (2013-2018)
Figure Global Insulins Sales Growth (2013-2018)
Figure Global Insulins Price (2013-2018)
Figure Global DPP-4 Inhibitors Sales Growth (2013-2018)
Figure Global DPP-4 Inhibitors Price (2013-2018)
Figure Global GLP-1 Receptor Agonists Sales Growth (2013-2018)
Figure Global GLP-1 Receptor Agonists Price (2013-2018)
Figure Global SGLT-2 Inhibitors Sales Growth (2013-2018)
Figure Global SGLT-2 Inhibitors Price (2013-2018)
Table Global Type 2 Diabetes Sales by Application (2013-2018)
Table Global Type 2 Diabetes Sales Share by Application (2013-2018)
Figure Global Hospital Sales Growth (2013-2018)
Figure Global Others Sales Growth (2013-2018)
Figure Global Type 2 Diabetes Sales, Revenue and Growth Rate (2018-2023)
Table Global Type 2 Diabetes Sales Forecast by Regions (2018-2023)
Table Global Type 2 Diabetes Market Share Forecast by Regions (2018-2023)
Figure North America Sales Type 2 Diabetes Market Forecast (2018-2023)
Figure Europe Sales Type 2 Diabetes Market Forecast (2018-2023)
Figure Asia-Pacific Sales Type 2 Diabetes Market Forecast (2018-2023)
Figure South America Sales Type 2 Diabetes Market Forecast (2018-2023)
Figure Middle East and Africa Sales Type 2 Diabetes Market Forecast (2018-2023)
Table Global Type 2 Diabetes Sales Forecast by Type (2018-2023)
Table Global Type 2 Diabetes Market Share Forecast by Type (2018-2023)
Table Global Type 2 Diabetes Sales Forecast by Application (2018-2023)
Table Global Type 2 Diabetes Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
